Read more about Bharat Biotech gives request to Brazilian regulator for Covaxin approval on Business Standard. Earlier, Anvisa denied permission to import Covaxin after its authorities found that the plant in which the jab is being made did not meet the Good Manufacturing Practice (GMP) requirements
Anvisa had earlier denied permission to import Covaxin after its authorities found that the plant in which the jab is being made did not meet the Good Manufacturing Practice requirements.
Bharat Biotech has signed an agreement with Brazil for supply of 20 million doses of Covaxin.
Hyderabad:
Bharat Biotech which faced a red flag from Brazil s health regulator for supply of COVID-19 vaccine Covaxin to that country over the issues of Good Manufacturing Practices in its plant, has filed a new request to the Brazilian authorities for certification.
According to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Ministry of Health of the South American country filed a new application for authorisation to import 20 million doses of the Covaxin.
Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.
Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.